MicroRNA-7 Functions As a Tumor-suppressor Gene by Regulating ILF2 in Pancreatic Carcinoma

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2017 Mar 6

PMID 28259961

Citations 22

Authors

Yiliang Bi

Wei Shen

Min Min

Yan Liu

Affiliations

Soon will be listed here.

Abstract

Interleukin enhancer binding factor 2 (ILF2) has been found to be markedly upregulated in pancreatic carcinoma and is involved in the pathogenesis of pancreatic carcinoma. Thus, ILF2 may be a potential target for therapy. Yet, the regulatory mechanisms of ILF2 in pancreatic carcinoma remain largely elusive. In the present study, we demonstrated that ILF2 functioned as an oncogene and regulated epithelial-mesenchymal transition (EMT)-associated genes in pancreatic carcinoma PANC-1 cells. MicroRNA-7 (miR-7) suppressed ILF2 mRNA expression and the protein level in PANC-1 cells. Contrary to ILF2, miRNA-7 functioned as a tumor-suppressor gene and negatively regulated EMT-associated genes in the PANC-1 cells. Curcumin, a polyphenol natural product isolated from the rhizome of the plant Curcuma longa, has emerged as a promising anticancer therapeutic agent. We found that treatment with curcumin increased miR-7 expression and suppressed ILF2 protein in the PANC-1 cells. Thus, we identified ILF2 as a new downstream target gene of curcumin. The results revealed that ILF2 is regulated by miR-7 and suggest that downregulation of miR-7 may be an important factor for the ILF2 overexpression in pancreatic carcinoma.

Citing Articles

ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target.

Sun T, Li X, Zhang Y, Zou B, Zhang Y Front Oncol. 2024; 14:1513979.

PMID: 39735599 PMC: 11671367. DOI: 10.3389/fonc.2024.1513979.

Interleukin-2 enhancer binding factor 2 negatively regulates the replication of duck hepatitis A virus type 1 by disrupting the RNA-dependent RNA polymerase activity of 3D polymerase.

An H, Yu X, Li J, Shi F, Liu Y, Shu M Vet Res. 2024; 55(1):40.

PMID: 38532469 PMC: 10967090. DOI: 10.1186/s13567-024-01294-x.

Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.

Morales-Martinez M, Vega M Int J Mol Sci. 2022; 23(16).

PMID: 36012357 PMC: 9408913. DOI: 10.3390/ijms23169091.

Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Pouliquen D, Boissard A, Henry C, Coqueret O, Guette C Front Pharmacol. 2022; 13:934534.

PMID: 35873564 PMC: 9304619. DOI: 10.3389/fphar.2022.934534.

Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).

Zhang H, Che Y, Xuan B, Wu X, Li H Bioengineered. 2022; 13(4):8785-8797.

PMID: 35333683 PMC: 9161932. DOI: 10.1080/21655979.2022.2051886.

References

Huang Q, He X, Qiu X, Liu X, Sun G, Guo J . Expression of NF45 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth. Tumour Biol. 2014; 35(10):10149-57. DOI: 10.1007/s13277-014-2310-5. View

Rossi J . New hope for a microRNA therapy for liver cancer. Cell. 2009; 137(6):990-2. DOI: 10.1016/j.cell.2009.05.038. View

Costello E, Greenhalf W, Neoptolemos J . New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol. 2012; 9(8):435-44. DOI: 10.1038/nrgastro.2012.119. View

Kim V . Small RNAs: classification, biogenesis, and function. Mol Cells. 2005; 19(1):1-15. View

Chen D, Huang J, Zhang K, Pan B, Chen J, De W . MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J Cancer. 2014; 50(17):3050-67. DOI: 10.1016/j.ejca.2014.09.008. View

Bracken C, Gregory P, Kolesnikoff N, Bert A, Wang J, Shannon M . A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008; 68(19):7846-54. DOI: 10.1158/0008-5472.CAN-08-1942. View

Kao P, Chen L, Brock G, Ng J, Kenny J, Smith A . Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem. 1994; 269(32):20691-9. View

Zuo J, Zhu W, Li M, Li X, Yi H, Zeng G . Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem. 2011; 112(9):2508-17. DOI: 10.1002/jcb.23175. View

Sankpal U, Nagaraju G, Gottipolu S, Hurtado M, Jordan C, Simecka J . Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species. Oncotarget. 2015; 7(3):3186-200. PMC: 4823099. DOI: 10.18632/oncotarget.6553. View

10.

Wolfgang C, Herman J, Laheru D, Klein A, Erdek M, Fishman E . Recent progress in pancreatic cancer. CA Cancer J Clin. 2013; 63(5):318-48. PMC: 3769458. DOI: 10.3322/caac.21190. View

11.

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

12.

Korpal M, Lee E, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283(22):14910-4. PMC: 3258899. DOI: 10.1074/jbc.C800074200. View

13.

Wan C, Gong C, Ji L, Liu X, Wang Y, Wang L . NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma. Mol Cell Biochem. 2015; 410(1-2):25-35. DOI: 10.1007/s11010-015-2535-7. View

14.

Reichman T, Muniz L, Mathews M . The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells. Mol Cell Biol. 2001; 22(1):343-56. PMC: 134226. DOI: 10.1128/MCB.22.1.343-356.2002. View

15.

Shamanna R, Hoque M, Peery T, Mathews M . Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells. Oncogene. 2012; 32(43):5176-85. PMC: 4032571. DOI: 10.1038/onc.2012.533. View

16.

Gregory P, Bracken C, Bert A, Goodall G . MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008; 7(20):3112-8. DOI: 10.4161/cc.7.20.6851. View

17.

Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A . The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772):901-6. DOI: 10.1038/35002607. View

18.

Dai X, Ge J, Wang X, Qian X, Zhang C, Li X . OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncol Rep. 2012; 29(1):155-60. DOI: 10.3892/or.2012.2086. View

19.

Kern S, Shi C, Hruban R . The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. J Pathol. 2010; 223(2):295-306. PMC: 3767138. DOI: 10.1002/path.2813. View

20.

Ni S, Zhu J, Zhang J, Zhang S, Li M, Ni R . Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC). Tumour Biol. 2014; 36(2):747-56. DOI: 10.1007/s13277-014-2683-5. View